Skip to main content

Harvard Bioscience Announces Executive Appointment

Written by Customer Service on . Posted in Public Companies.

HOLLISTON, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Ken Olson has been named Vice President and General Manager, Pre-Clinical Systems (DSI), reporting to Chairman, President and CEO, Jim Green.
Olson will lead the Pre-Clinical Systems Team, which is comprised of the Data Sciences International team focused on delivering market leading preclinical products, systems, and services to the drug discovery and development industry.Green said, “I am thrilled Ken is joining our team. This is a key appointment to the leadership team. Ken brings a strong track record in technology and development, operating leadership and strategic customer relationships.”Olson, formerly Sr. Vice President, Global Engineering and Operations at Spacelabs Healthcare, is a highly accomplished leader in strategic research and development for high technology products and is an expert in intellectual property development and licensing. Prior to joining Spacelabs, Ken held various leadership positions at ABT Molecular Imaging, Medtronic, and Cardiac Sciences. Ken holds a B.S. in Electrical Engineering and an MBA from the University of Minnesota.About Harvard BioscienceHarvard Bioscience is a global developer, manufacturer and marketer of a broad range of solutions to advance life science. Our products are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada and China. For more information, please visit our website at www.harvardbioscience.com.CONTACT:
Mike Rossi
Chief Financial Officer
Tel: 508 893 8999

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.